P r a w n - F r e s h ™

advertisement
P ra w n -F re s h ™
MATERIAL SAFETY DATA SHEET
XyRex® Ltd.
65 Rodney St
Glasgow G4 9SQ
www.xyrex.com
1. P r o d u c t a n d C o m p a n y In fo rm a tio n
®
P ro d u c t Id e n tific a tion / T ra d e N a m e : X y R e x P r a w n - F r e s h
A p p lic a tio n:
T o p re v en t m e la n o s is , c o n tro l b a c te ria a n d e x te n d s h e lf life s afe ly an d
natu ra lly, w itho ut the n e ed fo r s o d iu m m e ta -b is u lp h ite .
®
Co m pan y:
E m e rg e n c y P ho n e :
Is s u e d B y:
R e s p o n s ib le P e rs o n:
X yR e x L td
+ 4 4 (0)7712525413
John Davis
2 . C o m p o s itio n
Th e pro du ct is a liquid b len d of n on -ha z ard ou s fo od g rad e o rga n ic a c ids, ino rg a n ic b uffers n atu ra l p la n t extra cts and
antioxidants.
1
2
3
Nam e
N on -h a z a rd o u s polyphenols and
poly-phenol derivitives
O ther n o n -h a z a rd o u s o rg a n ic a nd
inorg anic ac ids a n d s a lts
C AS
N /R
C o n c e n tra tio n
5 -8 % w /w
C la s s ific a tio n
Ref point 9
N /R
15 -1 8 % w /w
Ref point 9
E 586 antioxidant (nature identical)
136-77-6
8-12% w/w
Ref point 9
3. Ha z a rd Id e n tifi c a tio n
T h e M a in h a z a rd :
M a y c a u s e s light irritation to e ye
H ealth Classification : N o n e
F ire C la s s ification :
none
4 . F ir s t A id / E m e r g e n c y A c tio n s
If th is h a p p e n s
P ro d u c t
P ro d u c t
P ro d u c t
P ro d u c t
o n S k in :
in E ye s :
In g e s te d :
In h a le d :
© X y R e x ® L td 2 0 0 5
D o th is
B rie f or o c c a s io n a l c on ta c t is u n lik e ly to h a v e a s ig n ific an t e ffe c t.
R in s e w ith p le n ty of w ater for at le a s t 1 0 m in ute s .
W a s h ou t m o uth w ith w a te r. E s s e n tia lly n o n -to x ic
U n lik e ly to o c c ur
pag e 1 of 3
The technical information and suggestions for use contained herein are believed to be reliable, but they are not to be construed as warranties
and no patent liability can be assumed.
P ra w n -F re s h ™
5 . F ir e F ig h tin g M e a s u re s
F ire H a z a r d :
E x tin g u is h in g M e d ia :
S p e c ia l P ro t e c ti ve
E q u ip m e n t:
O th e r In fo r m a tio n :
N on -fla m m a b le
6 . A c c id e n ta l R e le a s e o r S p illa g e
P e rs o n a l P r e c a u tio n s :
E n vir o n m e n t a l
P re c a u t io n s :
M e th o d s fo r c le a n -u p :
O th e r In fo r m a tio n :
U s e p ro te c tiv e e qu ip m e nt
F lu s h w ith c o p io u s a m o u n ts of w a te r.
7 . H a n d lin g a n d S to ra g e
H a n d lin g a n d S to ra g e
M a te r ia ls :
H a n d lin g a n d S to ra g e
P re c a u t io n s :
none
S to re in a c o o l, d r y a tm o s p he re, in clo s ed c o n ta in e rs a nd at a m b ie nt
te m p e ra tu re to m a inta in s h e lf life.
8. P e rs o n a l P r o te c tio n & E x p o s u re C o n t r o l
P ro te c tive E q u ip m e n t:
R e s p ira to r y P r o t e c tio n :
E x p o s u r e C o n tr o l:
N on -H a z a rd o u s
N on -H a z a rd o u s
9 . P h y s ic a l a n d C h e m ic a l P ro p e r tie s
O d ou r:
A p p ea ra n c e :
D e n sity (k g /m 3 ):
S lig h t c itru s .
pa le b ro w n m ilk y liq u id .
112 0 @ 2 0 o C
o
M e ltin g P o int ( C ):
o
o
< - 10 C
B o iling P o int ( C ):
100
pH (c o n c e ntra te)
pH (1 % s o lu tio n)
1.2
1.5
D e c o m poo s
FTla
s hition
do e s n ot fla s h
em
p.P(oo int
C ): ( C ):
A u to Ig n itio n T e m p .
( o C ):
n.d
U pper F la m m a b le
L im it:
Lo w er F la m m a b le
n.d
L im it:
S o lu b ility :
F u ll w a ter d is p e rs ib le.
V is c o s ity (c p s ):
.
10. S ta b ili ty a n d R e a c ti vit y
S ta b ility:
In c o m p a tib ilit y:
H a z a r d o u s D e c o m p o s itio n
P ro d u c ts :
© X y R e x ® L td 2 0 0 5
S ta b le u n der n o r m a l a m b ie n t c on d itio n s .
N o s ig n ific a nt in c o m p a tib ilitie s . D o no t s to re in c a rb o n s te e l.
none
page 2 of 3
The technical information and suggestions for use contained herein are believed to be reliable, but they are not to be construed as warranties
and no patent liability can be assumed.
P ra w n -F re s h ™
1 1 . T o x ic o lo g ic a l In fo r m a tio n
H e a lth E ffe c ts :
O n S k in :
O n E ye s :
O n In g e s tio n :
O n In h a la tio n :
C a n c e r:
C h r o n ic E ffe c ts :
O th e r T o x ic o lo g ic a l
In fo rm a tio n :
U n lik e ly to o c c u r.
M a y c a u s e irrita tio n after p ro lo ng e d or re p ea ted e x p o s u re .
N o s ig n ific a nt e ffe c ts a re lik e ly.
U n lik e ly to o c c u r.
T h e p ro d u c t c on ta ins n o k n o w n c a rc in o g e n s .
N ot d ete rm in e d.
1 2 . E c o lo g ic a l In fo r m a tio n
P ro d u c t w ill n ot b io a c c u m u la te.
B io d e g ra da tio n : A ll o rg a n ic in g re d ien ts a re b io d e g ra d a b le .
1 3 . D is p o s a l
D is p o s e o f la rg e qu a n titie s b y c o lle c tin g a s m u c h as p o s s ib le in a c lean c o n ta in er and m o v ing to a
s a fe p la c e for d is p o s a l. S m a ll re s id u e s c an b e a b s o rb e d in to s a n d or e a rth . D is p o s e o f a c c o rd in g to
lo c al re g u la tio n s .
1 4 . T ra n s p o rt In fo r m a tio n
P ro per S h ip p in g N a m e : N o t regu la te d .
T ra d e N a m e : X y R e x
®
P ra w n -F re s h .
A R D /R ID
C la s s :
U N N u m b e r:
P a c k ing G roup
H a z a rd Id en tific a tio n N u m b e r:
E m e rg e n c y A c tion C o d e (U K ):
IM D G
C la s s :
U N N u m b e r:
P a c k ing G roup :
M a rin e P o llu tan t:
E MS No :
M F A G T a b le N o :
T re m c a rd N o :
IA T A
C la s s :
S u b s id ia ry R is k s :
N ot re s tric ted
N ot re s tric ted
N ot re s tric te d
15. R e g u la to ry L a b e lli n g In fo r m a tio n
C la s s ific a tion :
N ot c la s s ifie d.
R is k P h ra s e s :
S a fe ty P h ra s e s :
1 6 . O th e r In fo r m a tio n :
D o c u m e n t N o .: 2 0 2 0
D ate of Is s ue : 5 T H May 2009.
© X y R e x ® L td 2 0 0 5
page 3 of 3
The technical information and suggestions for use contained herein are believed to be reliable, but they are not to be construed as warranties
and no patent liability can be assumed.
Download